Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury

Journal of Cellular Biochemistry

Volumn 84, Issue 3, 2002, Pages 575-582

  Fahmy, Roger G ^a   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antisense RNA; Egr 1; Injury; Proliferation; Smooth muscle cells

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; EARLY GROWTH RESPONSE FACTOR 1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

CUCUMBER MOSAIC VIRUS; MURINAE; VECTORS;

EID: 0035698533     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10057     Document Type: Article

References (46)

1. Antisense oligonucleotides to the p65 subunit of NF-kβ inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries
2. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery: Dissecting the mechanism of action
3. Inhibition of vascular mooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides
4. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides
5. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-β type II receptor
6. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
7. Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model
8. Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase
9. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications forantisense technology
10. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors
11. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix
12. Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury
13. Nonsequence- specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides
14. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo
15. Suppression of gene expression by targeted disruption of messenger RNA: Available options and current stratergies
16. Inducible expression of Egr-1-dependent genes: A paradigm of transcriptional activation in vascular endothelium
17. Egr-1-induced endothelial gene expression: A common theme in vascular injury
18. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery
19. Characterization of cloned aortic smooth muscle cells from young rats
20. A cascade model for restenosis
21. Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo
22. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury
23. Sequence context of antisense Re1A/NF-kappaβ phosphorothioates determines specificity
24. Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl triester, methyl phosphonate and phosphorothioate linkages
25. High-level expression of Egr-1 and Egr-1inducible genes in mouse and human atherosclerosis
26. Single intraluminal delivery of antisense cdc2 kinase and proliferatingcell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia
27. Sequence-independent induction of Spl transcription factor activity by phosphorothioate oligodeoxynucleotides
28. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb
29. Clinical trials of restenosis after coronary angioplasty
30. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointimal formation in murine and human blood vessels
31. The pathogenesis of atherosclerosis: A perspective for the 1990s
32. Atherosclerosis: An inflammatory disease
33. Egr-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2
34. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth factor injury
35. Developmentally regulated production of platelet-derived growth factor-like molecules
36. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
37. Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, and the nuclear interior
38. Inducible PDGF A-chain transcription in vascular smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3
39. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
40. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening
41. Controversies in the cellular pharmacology of oligodeoxynucleotides
42. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL-60 cells
43. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months
44. Adenovirus-mediated transfer of a dominant negative Hras suppresses neointimal formation in balloon-injured arteries in vivo
45. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury
46. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites